D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Microsoft
MSFT
|
+$549M |
| 2 |
Tesla
TSLA
|
+$538M |
| 3 |
Pinduoduo
PDD
|
+$357M |
| 4 |
Intel
INTC
|
+$261M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$255M |
Top Sells
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$398M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$300M |
| 3 |
Procter & Gamble
PG
|
+$281M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 5 |
JPMorgan Chase
JPM
|
+$250M |
Sector Composition
| 1 | Technology | 20.4% |
| 2 | Healthcare | 13.71% |
| 3 | Financials | 11.95% |
| 4 | Consumer Discretionary | 11.45% |
| 5 | Industrials | 7.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Alpha and Omega Semiconductor
AOSL
$882M
| $592K | ﹤0.01% |
20,728
-17,523
| -46% | -$501K |
|
2502
Ultra Clean Holdings
UCTT
$1.17B
| $589K | ﹤0.01% |
17,781
-42,278
| -70% | -$1.4M |
|
2503
Zynex
ZYXI
$44.8M
| $589K | ﹤0.01% |
42,363
+24,307
| +135% | +$338K |
|
2504
Dave & Buster's
PLAY
$696M
| $588K | ﹤0.01% |
16,590
-125,201
| -88% | -$4.44M |
|
2505
eGain
EGAN
$242M
| $587K | ﹤0.01% |
65,048
+3,084
| +5% | +$27.8K |
|
|
IVC
2506
DELISTED
Invacare Corporation
IVC
| $586K | ﹤0.01% |
1,394,763
| – | – |
|
2507
Ooma
OOMA
$351M
| $578K | ﹤0.01% |
42,460
-20,140
| -32% | -$274K |
|
2508
Banco de Chile
BCH
$15.1B
| $577K | ﹤0.01% |
+27,695
| New | +$577K |
|
2509
APi Group
APG
$14.7B
| $576K | ﹤0.01% |
45,909
-191,772
| -81% | -$2.4M |
|
2510
Crinetics Pharmaceuticals
CRNX
$3.18B
| $575K | ﹤0.01% |
31,417
-5,738
| -15% | -$105K |
|
2511
Caesarstone
CSTE
$48.4M
| $575K | ﹤0.01% |
100,632
+36,642
| +57% | +$209K |
|
2512
Bright Horizons
BFAM
$6.21B
| $574K | ﹤0.01% |
9,090
-75,841
| -89% | -$4.79M |
|
2513
Vitamin Cottage Natural Grocers
NGVC
$827M
| $573K | ﹤0.01% |
62,727
+24,279
| +63% | +$222K |
|
2514
ITT
ITT
$14B
| $571K | ﹤0.01% |
7,038
-4,191
| -37% | -$340K |
|
2515
Artivion
AORT
$1.88B
| $571K | ﹤0.01% |
47,083
+18,452
| +64% | +$224K |
|
2516
Evertec
EVTC
$2.12B
| $570K | ﹤0.01% |
17,617
+8,225
| +88% | +$266K |
|
2517
Alcon
ALC
$38.3B
| $570K | ﹤0.01% |
8,319
-6,481
| -44% | -$444K |
|
2518
Evolv Technologies
EVLV
$1.45B
| $570K | ﹤0.01% |
+219,976
| New | +$570K |
|
|
KRON
2519
DELISTED
Kronos Bio
KRON
| $569K | ﹤0.01% |
351,514
+43,167
| +14% | +$69.9K |
|
2520
Berry Corp
BRY
$311M
| $569K | ﹤0.01% |
71,091
-35,860
| -34% | -$287K |
|
2521
National Fuel Gas
NFG
$7.92B
| $568K | ﹤0.01% |
+8,968
| New | +$568K |
|
2522
International Bancshares
IBOC
$4.33B
| $565K | ﹤0.01% |
12,350
-29,667
| -71% | -$1.36M |
|
2523
CRISPR Therapeutics
CRSP
$5.57B
| $565K | ﹤0.01% |
+13,900
| New | +$565K |
|
2524
Luxfer Holdings
LXFR
$367M
| $561K | ﹤0.01% |
40,862
+6,416
| +19% | +$88K |
|
2525
Puma Biotechnology
PBYI
$234M
| $559K | ﹤0.01% |
132,184
-406,360
| -75% | -$1.72M |
|